Scinovex
review Open AccessTop 1% cited

Epidemiology of Glioblastoma Multiforme–Literature Review

Cancers · 2022 · Vol. 14(10) · pp. 2412–2412
Szymon GrochansAnna Maria CybulskaDonata SimińskaJan KorbeckiKlaudyna KojderDariusz ChlubekIrena Baranowska‐Bosiacka

Abstract

Glioblastoma multiforme (GBM) is one of the most aggressive malignancies, with a median overall survival of approximately 15 months. In this review, we analyze the pathogenesis of GBM, as well as epidemiological data, by age, gender, and tumor location. The data indicate that GBM is the higher-grade primary brain tumor and is significantly more common in men. The risk of being diagnosed with glioma increases with age, and median survival remains low, despite medical advances. In addition, it is difficult to determine clearly how GBM is influenced by stimulants, certain medications (e.g., NSAIDs), cell phone use, and exposure to heavy metals.

Glioma Diagnosis and TreatmentFerroptosis and cancer prognosisRadiomics and Machine Learning in Medical ImagingEpidemiologyGlioblastomaMedicineGliomaOncologyPathogenesisInternal medicineBrain tumorPathologyBioinformatics

Funding

  • Pomorski Uniwersytet Medyczny W Szczecinie
Citations
543
FWCI
80.16
field-weighted impact
References
290
Percentile
100%
vs. same field & year
Citations per year
References
MAP kinase signalling pathways in cancer
Oncogene · 2007 · 2,984 citations
Estrogen production and action
Journal of the American Academy of Dermatology · 2001 · 814 citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
New England Journal of Medicine · 2005 · 21,276 citations
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
New England Journal of Medicine · 2005 · 7,163 citations
The Somatic Genomic Landscape of Glioblastoma
Cell · 2013 · 5,082 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.